25 years of lipid-lowering therapy: secular trends in therapy of coronary patients
Wiener klinische Wochenschrift(2024)
摘要
Guidelines on dyslipidemia and lipid-lowering therapy (LLT) over the years recommend lower low-density lipoprotein cholesterol (LDL-C) goals by more intense therapy. Nevertheless, LDL‑C has increased in the general population. Real-world trends of LLT medication as well as of LDL‑C levels in cardiovascular high-risk patients are unclear. From 2158 patients who were referred for elective coronary angiography, lipid medication was analyzed at admission in three cardiovascular observational studies (OS) over the last 25 years: OS1: 1999–2000, OS2: 2005–2008 and OS3: 2022–2023. The three studies were performed at the same cardiology unit of a tertiary care hospital in Austria. The proportion of patients without LLT significantly decreased from OS1 through OS2 to OS3 (49.4
更多查看译文
关键词
Cardiovascular disease,LDL cholesterol,Statin,Coronary angiography,ESC/EAS guidelines
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要